Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer

Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer

ABSTRACT Background Patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) require complex management strategies. This study evaluated the prognostic significance of the perichemotherapy skeletal muscle index (SMI) and carbohydrate antigen 19‐9 (CA 19‐9) in patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji Hye Min, Jeong Il Yu, Seong Hyun Kim, Young Kon Kim, Kangpyo Kim, Hee Chul Park, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Ho Choi, Jin Seok Heo, In Woong Han, Hongbeom Kim, Sang Hyun Shin, So Jung Yoon, Sook‐young Woo
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
FOLFIRINOX
locoregional treatments
pancreatic ductal adenocarcinoma
sarcopenia
skeletal‐muscle‐index changes
Online Access:https://doi.org/10.1002/jcsm.13643
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jcsm.13643

Similar Items